These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 24788965

  • 21. Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?
    Kassassir H, Siewiera K, Sychowski R, Watała C.
    Pharmacol Rep; 2013; 65(4):870-83. PubMed ID: 24145081
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Suppression of Human Platelet Activation via Integrin αIIbβ3 Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene.
    Hsia CW, Tsai CL, Sheu JR, Lu WJ, Hsia CH, Velusamy M, Jayakumar T, Li JY.
    Int J Mol Sci; 2019 Nov 08; 20(22):. PubMed ID: 31717348
    [Abstract] [Full Text] [Related]

  • 24. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
    Pang JH, Coupland LA, Freeman C, Chong BH, Parish CR.
    Clin Exp Metastasis; 2015 Jun 08; 32(5):495-505. PubMed ID: 25982688
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The Antithrombotic Agent Pterostilbene Interferes with Integrin αIIbβ3-Mediated Inside-Out and Outside-In Signals in Human Platelets.
    Huang WC, Lin KC, Hsia CW, Hsia CH, Chen TY, Bhavan PS, Sheu JR, Hou SM.
    Int J Mol Sci; 2021 Mar 31; 22(7):. PubMed ID: 33807403
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of aflibercept on platelet activation profile.
    Sobolewska B, Golenko J, Poeschel S, Grimmel C, Gatsiou A, Sopova K, Biedermann T, Schenke-Layland K, Stellos K, Ziemssen F.
    Exp Eye Res; 2018 Oct 31; 175():166-172. PubMed ID: 29908884
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Glatiramer acetate for treatment of MS: regulatory B cells join the cast of players.
    Van Kaer L.
    Exp Neurol; 2011 Jan 31; 227(1):19-23. PubMed ID: 20969865
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M, Jeong D, Kwon HW, Shin JH, Park SJ, Kwak D, Kim TH, Lee DH, Park HJ, Rhee MH.
    Vascul Pharmacol; 2018 Oct 31; 109():45-55. PubMed ID: 29890296
    [Abstract] [Full Text] [Related]

  • 37. CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
    Tyler AF, Mendoza JP, Firan M, Karandikar NJ.
    PLoS One; 2013 Oct 31; 8(6):e66772. PubMed ID: 23805274
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.